Camille L. Bedrosian, Chief Medical Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 5,421 shares at $5.54 ($30K) on 2024-12-02, disclosed to the SEC on 2024-12-03.
Open-market sale of $30k AMLX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AMLX | SELL | 2025-12-03 | $94K | — | Filing → |
| AMLX | SELL | 2025-10-02 | $351K | — | Filing → |
| AMLX | SELL | 2025-04-02 | $43K | — | Filing → |